Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | PTPRA | P18433 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5326890 | 0.83 | CYP1A2 (0.71) | CYP1A2SLC7A5HSD17B10PTGS1ALPI | |
| SCHEMBL21946220 | 0.81 | CYP1A2 (0.68) | CYP1A2P2RX7CTDSP1VNN1PTGS2 | |
| Hydrochloric Acid SCHEMBL29657231 | 0.80 | CYP1A2 (0.66) | CYP1A2P2RX7CTDSP1VNN1PTGS2 | |
| Hydrochloric Acid SCHEMBL28366679 | 0.80 | CYP1A2 (0.66) | CYP1A2P2RX7CTDSP1VNN1PTGS2 | |
| Hydrochloric Acid SCHEMBL28366682 | 0.80 | CYP1A2 (0.66) | CYP1A2P2RX7CTDSP1VNN1PTGS2 | |
| SCHEMBL29401000 | 0.77 | PTPRA (0.67) | CYP1A2SLC7A5HSD17B10PTGS1ALPI | |
| SCHEMBL22409316 | 0.77 | PTPRA (0.67) | CYP1A2SLC7A5HSD17B10PTGS1ALPI | |
| SCHEMBL29805516 | 0.77 | PTPRA (0.67) | CYP1A2SLC7A5HSD17B10PTGS1ALPI | |
| SCHEMBL126508 | 0.77 | PTPRA (0.67) | CYP1A2SLC7A5HSD17B10PTGS1ALPI | |
| SCHEMBL126509 | 0.77 | PTPRA (0.67) | CYP1A2SLC7A5HSD17B10PTGS1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | CYP1A2 4851/4885SLC7A5 3712/4885HSD17B10 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.